About the Guest: Dr. Jeff Ubersax is CEO of the biotechnology company Demetrix (who supported this episode). Jeff has a PhD in biochemistry from the University of California-San Francisco and is an expert in yeast biochemistry and genetics.
Episode Summary: Jeff Ubersax, PhD discusses the science behind how Demetrix is engineering baker's yeast to produce cannabinoids at an industrial scale, with a focus on making rare cannabinoids other than THC and CBD.
Jeff also discussed how he transitioned from academic science to running his own company, and offered advice for academic scientists in training who might be thinking about moving into biotechnology.
Relevant Links:
Kommentare